BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer

@inproceedings{Kuang2017BST2CC,
  title={BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer},
  author={Chun-mei Kuang and Xiang Fu and Yi-jun Hua and Wen-di Shuai and Zhi-hua Ye and Yingchang Li and Qi-hua Peng and Yi-zhuo Li and Shuai X. Chen and Chao-nan Qian and Wenlin Huang and Ran-yi Liu},
  booktitle={Cell death & disease},
  year={2017}
}
Concurrent/adjuvant cisplatin-based chemoradiotherapy is regarded as the standard of treatment for locoregionally advanced nasopharyngeal carcinoma (NPC). However, patients who do not respond to cisplatin suffer, rather than benefit, from chemotherapy treatment. The goal of this study was to identify molecules involved in cisplatin resistance and to clarify their molecular mechanisms, which would help in the discovery of potential therapeutic targets and in developing a personalized and precise… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 51 references

Similar Papers

Loading similar papers…